Perspective Therapeutics
CATX
52 hedge funds and large institutions have $16M invested in Perspective Therapeutics in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 8 closing their positions.
60% more capital invested
Capital invested by funds: $9.99M → $16M (+$6.03M)
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
6% more funds holding
Funds holding: 49 → 52 (+3)
0% more ownership
Funds ownership: 1.3% → 1.31% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
+$450K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$111K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$52.1K |
| 4 |
PIC
Portland Investment Counsel
Burlington,
Ontario, Canada
|
+$40.1K |
| 5 |
Morgan Stanley
New York
|
+$16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$555K |
| 2 |
Jane Street
New York
|
-$37.7K |
| 3 |
HF
HRT Financial
New York
|
-$23.2K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$21K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$17.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
BNP Paribas Financial Markets
Paris,
France
| $15 | – | – | – |
|
|
TSS
52
Two Sigma Securities
New York
| – | -$21K | -7,657 | Closed |
|
|
53
Cetera Investment Advisers
Schaumburg,
Illinois
| – | -$17.8K | -6,500 | Closed |
|
54
LPL Financial
San Diego,
California
| – | -$7.3K | -2,666 | Closed |
|
55
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$5.29K | -1,934 | Closed |
|
|
KL
56
KilterHowling LLC
Boulder,
Colorado
| – | -$4K | -1,463 | Closed |
|
57
Goldman Sachs
New York
| – | -$3.66K | -1,337 | Closed |
|
|
VF
58
Virtu Financial
New York
| – | -$3K | -1,273 | Closed |
|
59
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$563 | -200 | -90% |
|
|
CCM
60
Chilton Capital Management
Houston,
Texas
| – | -$137 | -50 | Closed |
|
CATX Hedge Fund Activity: Q4 2023 in Review
52 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q4 2023, worth a combined $16M — up 60% from $9.99M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CATX positions and 8 closed out — a net gain of 3 holders — while 9 added to existing stakes and 8 trimmed.
The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $450K. The largest seller was Perkins Capital Management, cutting an estimated $555K.
- 52 institutional investors held Perspective Therapeutics (CATX) as of Q4 2023, up from 49 in Q3 2023.
- Funds reported $16M of Perspective Therapeutics stock for Q4 2023, up 60% quarter-over-quarter.
- 11 funds opened new Perspective Therapeutics positions in Q4 2023 and 8 closed out, a net change of +3 holders.
- The largest Perspective Therapeutics buyer in Q4 2023 was Ghost Tree Capital, an estimated $450K added.
- The largest Perspective Therapeutics seller in Q4 2023 was Perkins Capital Management, an estimated $555K sold.
Based on aggregated 13F filings for Q4 2023.